Roll-call vote · 20 January 2026

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest ***I

Amendments by the committee responsible – separate vote

Part of: 2025/0102(COD) · first reading
Adopted
For 450Against 205Abstain 8

This is the vote on Amendment 164. We record the outcome and the full roll-call below — but not the amendment’s wording: what it proposed to change isn’t in our data yet (it lives in the tabled-amendment documents, which we don’t ingest).

How the vote split

for · against · abstain

By political group

PPE177·4·1
S-D76·48·0
PFE7·72·0
ECR62·10·1
RENEW62·5·0
VERTS-ALE50·0·0
THE-LEFT3·35·0
NI13·7·6
ESN0·24·0

By country

Germany64·25·0
France31·42·0
Italy52·21·0
Spain44·9·0
Poland42·7·0
Romania22·7·1
Netherlands18·10·1
Greece7·11·3
Czechia9·9·2

Every vote cast

663 recorded positions
Download CSVShowing 1–10 of 663
Abir AL-SAHLANIRENEW · SWEAgainst
Adam BIELANECR · POLFor
Adam JARUBASPPE · POLFor
Adina VĂLEANPPE · ROUFor
Adnan DIBRANIS-D · SWEFor
Afroditi LATINOPOULOUPFE · GRCAgainst
Alberico GAMBINOECR · ITAFor
Aleksandar NIKOLICPFE · FRAAgainst
Alessandra MORETTIS-D · ITAFor